Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression data from tamoxifen treated and control injection treated Tg(αMHC-MerCreMer) and wild type mus musculus.


ABSTRACT: α-myosin heavy chain promoter controlled MerCreMer expression enables conditional, cardiomyocyte specific and tamoxifen dependent gene inactivation of floxed genes. Administration of tamoxifen has been linked to development of acute and transient cardiomyopathy. The mechanism for this is unknown. We used microarrays to sort out factors relevant for adverse effects following tamoxifen dependent gene inactivation, to develop a protocol with minimal adverse effects, and to identify the most proper control animals. Mus musculus Tg(αMHC-MerCreMer) and wild type were sacrificed 4 days after 1 or 4 consecutive days of 40 mg/kg tamoxifen injected intraperitoneally, or after corresponding control injection treatment.

ORGANISM(S): Mus musculus

SUBMITTER: Karina Hougen 

PROVIDER: E-GEOD-19344 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2010-09-01 | GSE19344 | GEO
2015-10-31 | E-GEOD-74518 | biostudies-arrayexpress
2015-10-31 | GSE74518 | GEO
2017-11-30 | GSE86230 | GEO
2017-11-30 | GSE86231 | GEO
| PRJNA121721 | ENA
2015-07-24 | E-GEOD-63759 | biostudies-arrayexpress
2012-05-03 | E-GEOD-34232 | biostudies-arrayexpress
2017-12-21 | GSE84142 | GEO
2010-10-01 | E-GEOD-22295 | biostudies-arrayexpress